Study Reveals Gold Nanoparticles Can Boost Cancer Treatment Effectiveness by 40 Percent
PITTSBURGH, PA — A groundbreaking study published this week in the journal *Nature Nanotechnology* has found that gold nanoparticles, when combined with standard radiotherapy, can increase the destruction of malignant tumors by an average of 40 percent. Researchers at the University of Pittsburgh Medical Center conducted clinical trials on 120 patients with advanced solid tumors, half of whom received the gold-enhanced treatment. The particles, measuring just 15 nanometers in diameter, are designed to accumulate in cancer cells and amplify the radiation dose delivered to the tissue while sparing healthy cells. Dr. Elena Vasquez, the lead author, stated that the treatment has shown no significant side effects beyond those of standard radiotherapy. The findings are expected to accelerate the approval process for the new therapy, which could become widely available within two years.